Skip to content

Symptoms and Functional Syndromes

Last updated:

Endocrine tumors can be functional (producing excess hormones) or non-functional (causing symptoms by pressing on nearby organs). Functional tumors cause specific syndromes like carcinoid syndrome or Cushing's, while non-functional tumors often remain silent until they grow large.

Key Takeaways

  • Functional endocrine tumors actively release hormones, causing systemic symptoms like flushing, weight gain, or low blood sugar.
  • Non-functional tumors do not secrete hormones and often only cause symptoms when they grow large enough to press on nearby organs.
  • Carcinoid syndrome is a common functional syndrome characterized by sudden skin flushing, diarrhea, and wheezing.
  • Doctors use general blood markers like Chromogranin A (CgA) and specific hormone tests to diagnose and monitor endocrine tumors.
  • Certain acid-reflux medications and specific foods can cause false positives on endocrine tumor laboratory tests.

Endocrine tumors are broadly categorized into two groups based on how they behave in your body: functional and non-functional. Understanding this distinction is the first step in recognizing why you may be feeling certain symptoms and how your medical team will approach your care [1][2].

Functional Tumors: The “Hormone Secretors”

A functional tumor is one that actively produces and releases hormones into your bloodstream [1]. Because these hormones act as chemical messengers, even a very small tumor can cause widespread, systemic symptoms throughout your entire body [3][4].

Common Functional Syndromes

  • Carcinoid Syndrome: Often caused by tumors in the digestive tract or lungs, this syndrome typically presents with a “triad” of symptoms: sudden skin flushing (redness and warmth), diarrhea, and wheezing [5][6]. In advanced cases, it can affect the heart valves [7]. Important: Patients with carcinoid syndrome are at risk for a Carcinoid Crisis—a severe, life-threatening exacerbation of symptoms often triggered by physical stress, anesthesia, or surgery. Always advocate for prophylactic IV octreotide before any surgical or dental procedure [8].
  • Cushing’s Syndrome: Caused by excess cortisol (the stress hormone), often from adrenal or pituitary tumors. Symptoms include high blood pressure, high blood sugar, a “moon-shaped” face, weight gain around the midsection, and thin skin that bruises easily [9][10].
  • Insulinoma: These tumors in the pancreas secrete excess insulin, leading to hypoglycemia (low blood sugar). You may feel shaky, sweaty, confused, or faint, especially after fasting [11][12].
  • Acromegaly: Caused by too much growth hormone, usually from a pituitary tumor. It progresses slowly over years, causing hands and feet to enlarge, facial features to coarsen (like a protruding jaw or brow), and deepening of the voice [13][14][15].
  • Hypercalcemia: Often resulting from parathyroid tumors, too much parathyroid hormone (PTH) pulls calcium out of your bones and into your blood. This can lead to “stones, bones, and groans”—kidney stones, bone pain or fractures, and abdominal discomfort [16][17][18].

Non-Functional Tumors: The “Silent Growers”

Non-functional tumors do not produce hormones [1]. Because they don’t cause the “spells” or systemic changes seen with functional tumors, they are often discovered later, either during imaging for an unrelated issue or when they become large enough to press on nearby structures [2][19].

Mass Effect Symptoms

When a tumor grows large enough to physically push on other organs or nerves, it creates what doctors call a mass effect [20][21].

  • Pituitary Gland: A tumor here can press on the optic chiasm (where the eye nerves cross), leading to vision loss, particularly in your peripheral (side) vision. It can also cause persistent, migraine-like headaches [22][23][24].
  • Pancreas: A tumor in the “head” of the pancreas can block the bile duct, leading to jaundice (yellowing of the skin and eyes). It may also cause abdominal pain, a feeling of fullness after eating very little, or digestive issues [25][26].
  • General Effects: Large tumors can also cause hypopituitarism, where the tumor crushes the healthy part of a gland, preventing it from making the normal amount of hormones you need for energy and health [27][28].

Diagnosis and Monitoring

Whether a tumor is functional or non-functional, doctors often monitor a protein called Chromogranin A (CgA) in the blood, which serves as a general marker for many endocrine tumor types [3][29]. Note: CgA levels can be falsely elevated by common acid-reflux medications like Proton Pump Inhibitors (PPIs). Ask your doctor if you should pause these before a blood draw.

Functional tumors require more specific tests, such as a 24-hour urine collection for cortisol, a 72-hour fast to monitor blood sugar, or a 5-HIAA test for serotonin [30][11]. For 5-HIAA testing, you must follow a strict diet, avoiding serotonin-rich foods like bananas, avocados, and walnuts before and during the collection to prevent false positives [31].

Symptoms are highly variable; some people have severe symptoms from a tiny tumor, while others have few symptoms despite a larger one. Always report any new or “odd” physical changes to your care team [32][3].

Frequently Asked Questions

What is the difference between a functional and non-functional endocrine tumor?
A functional tumor actively produces and releases excess hormones into your bloodstream, causing body-wide symptoms. A non-functional tumor does not produce hormones and typically only causes symptoms if it grows large enough to press on nearby organs or nerves.
What are the signs of carcinoid syndrome?
Carcinoid syndrome typically causes a triad of symptoms, including sudden skin flushing, diarrhea, and wheezing. These symptoms occur when a functional tumor releases excess hormones like serotonin into the body.
Can acid reflux medication affect my endocrine tumor blood tests?
Yes, common acid-reflux medications like proton pump inhibitors can falsely elevate Chromogranin A (CgA) levels. You should ask your doctor if you need to pause these medications before having your blood drawn.
Why do I need to follow a special diet before a 5-HIAA test?
The 5-HIAA test measures serotonin levels, so eating foods naturally high in serotonin can cause a false positive result. You will need to avoid foods like bananas, avocados, and walnuts before and during the urine collection.
What does it mean if my tumor is causing a mass effect?
A mass effect occurs when a non-functional tumor grows large enough to physically press on nearby structures. Depending on the tumor's location, this can cause symptoms like vision loss, persistent headaches, or jaundice.

Questions for Your Doctor

  • Based on my symptoms and labs, is my tumor classified as 'functional' or 'non-functional'?
  • If my tumor is functional, which specific hormone is it overproducing and what are the long-term effects of that hormone?
  • What tumor markers, such as Chromogranin A (CgA) or 5-HIAA, will we use to monitor my condition?
  • Do I need to pause any medications like Proton Pump Inhibitors (PPIs) before my blood tests?
  • For my non-functional tumor, is it currently pressing on any vital structures like the optic chiasm or bile duct?
  • Will I need specialized testing, like a 72-hour fast or a dexamethasone suppression test, to confirm my diagnosis?

Questions for You

  • Have I noticed subtle changes in my appearance, like my rings feeling tighter, my shoe size increasing, or my facial features becoming more pronounced?
  • Am I experiencing 'spells' of symptoms, such as sudden skin flushing, diarrhea, or heart palpitations that come and go?
  • Have I had any 'low sugar' moments where I feel shaky, sweaty, or confused, especially after not eating for a while?
  • Am I having trouble seeing things to my left or right (peripheral vision), or am I getting new, persistent headaches?
  • Have I noticed any yellowing of my eyes or skin, or unexplained pain in my upper abdomen?

Want personalized information?

Type your question below to get evidence-based answers tailored to your situation.

References

  1. 1

    The Pancreatic Endocrine Tumors - Experience of First Surgical Clinic Iasi.

    Târcoveanu E, Lupascu C, Vasilescu A, et al.

    Chirurgia (Bucharest, Romania : 1990) 2019; (114(5)):639-649.

    PMID: 31670640
  2. 2

    Diagnosis and Treatment of Pituitary Adenomas: A Review.

    Molitch ME

    JAMA 2017; (317(5)):516-524 doi:10.1001/jama.2016.19699.

    PMID: 28170483
  3. 3

    Gastrointestinal neuroendocrine tumors in 2020.

    Ahmed M

    World journal of gastrointestinal oncology 2020; (12(8)):791-807 doi:10.4251/wjgo.v12.i8.791.

    PMID: 32879660
  4. 4

    Neoplasms of the Neuroendocrine Pancreas: An Update in the Classification, Definition, and Molecular Genetic Advances.

    Guilmette JM, Nosé V

    Advances in anatomic pathology 2019; (26(1)):13-30 doi:10.1097/PAP.0000000000000201.

    PMID: 29912000
  5. 5

    Carcinoid Syndrome: A Review.

    Gade AK, Olariu E, Douthit NT

    Cureus 2020; (12(3)):e7186 doi:10.7759/cureus.7186.

    PMID: 32257725
  6. 6

    Carcinoid syndrome: update on the pathophysiology and treatment.

    Rubin de Celis Ferrari AC, Glasberg J, Riechelmann RP

    Clinics (Sao Paulo, Brazil) 2018; (73(suppl 1)):e490s doi:10.6061/clinics/2018/e490s.

    PMID: 30133565
  7. 7

    Hedinger Syndrome: A Rare Cardiac Manifestation of Carcinoid Syndrome.

    Ghukasyan H

    Cureus 2022; (14(7)):e26528 doi:10.7759/cureus.26528.

    PMID: 35795576
  8. 8

    New and Emerging Treatment Options for Gastroenteropancreatic Neuroendocrine Tumors.

    Phan AT, Kunz PL, Reidy-Lagunes DL

    Clinical advances in hematology & oncology : H&O 2015; (13(5 Suppl 5)):1-18; quiz 1 p following 18.

    PMID: 26430956
  9. 9

    A rare case of an ACTH/CRH co-secreting midgut neuroendocrine tumor mimicking Cushing's disease.

    Streuli R, Krull I, Brändle M, et al.

    Endocrinology, diabetes & metabolism case reports 2017; (2017()) doi:10.1530/EDM-17-0058.

    PMID: 28680643
  10. 10

    A rare case of ectopic cushing's syndrome caused by renal neuroendocrine tumor.

    Sehatpour F, Panahi N, Ramezani-Binabaj M, et al.

    Journal of diabetes and metabolic disorders 2026; (25(1)):79 doi:10.1007/s40200-026-01878-8.

    PMID: 41757383
  11. 11

    Use of Selective Arterial Calcium Stimulation Testing in Identification of Insulinoma in a Patient After Bariatric Surgery.

    Szczepanski JM, Hissong E, Manthei DM

    Laboratory medicine 2022; (53(2)):e40-e43 doi:10.1093/labmed/lmab071.

    PMID: 34480182
  12. 12

    Biochemical Testing in Patients with Neuroendocrine Tumors.

    Granberg D

    Frontiers of hormone research 2015; (44()):24-39 doi:10.1159/000381981.

    PMID: 26303702
  13. 13

    Acromegaly: clinical features at diagnosis.

    Vilar L, Vilar CF, Lyra R, et al.

    Pituitary 2017; (20(1)):22-32 doi:10.1007/s11102-016-0772-8.

    PMID: 27812777
  14. 14

    A Comprehensive Review of Four Clinical Practice Guidelines of Acromegaly.

    Ogedegbe OJ, Cheema AY, Khan MA, et al.

    Cureus 2022; (14(9)):e28722 doi:10.7759/cureus.28722.

    PMID: 36105896
  15. 15

    Acromegaly in humans and cats: Pathophysiological, clinical and management resemblances and differences.

    Lopes-Pinto M, Marques PL, Lacerda-Nobre E, et al.

    Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society 2024; (76()):101595 doi:10.1016/j.ghir.2024.101595.

    PMID: 38810595
  16. 16

    Primary hyperparathyroidism due to a giant parathyroid adenoma presenting with pathological fractures and multiple brown tumors.

    Meng J, Aboznadah WM, Pusztaszeri M, Larouche V

    Endocrinology, diabetes & metabolism case reports 2024; (2024(4)).

    PMID: 39700332
  17. 17

    Giant parathyroid adenoma diagnosed by brown tumour, a clinical manifestation of primary hyperparathyroidism: A case report.

    Yigit B, Tanal M, Citgez B

    JPMA. The Journal of the Pakistan Medical Association 2021; (71(4)):1266-1269 doi:10.47391/JPMA.393.

    PMID: 34125787
  18. 18

    Three pediatric patients with primary hyperparathyroidism caused by parathyroid adenoma.

    Oh A, Lee Y, Yoo HW, Choi JH

    Annals of pediatric endocrinology & metabolism 2022; (27(2)):142-147 doi:10.6065/apem.2142006.003.

    PMID: 34015897
  19. 19

    Cdk5 drives formation of heterogeneous pancreatic neuroendocrine tumors.

    Carter AM, Kumar N, Herring B, et al.

    Oncogenesis 2021; (10(12)):83 doi:10.1038/s41389-021-00372-5.

    PMID: 34862365
  20. 20

    Duodenal perforation as presentation of gastric neuroendocrine tumour: A case report.

    Di Buono G, Bonventre G, Badalamenti G, et al.

    International journal of surgery case reports 2020; (77S()):S105-S108 doi:10.1016/j.ijscr.2020.09.120.

    PMID: 32981880
  21. 21

    Neuroendocrine Neoplasms.

    Kamboj S, Guerra-Bauman F, Mahmud H, Waheed A

    Primary care 2024; (51(3)):549-560 doi:10.1016/j.pop.2024.04.010.

    PMID: 39067978
  22. 22

    Clinical Concerns about Recurrence of Non-Functioning Pituitary Adenoma.

    Lee MH, Lee JH, Seol HJ, et al.

    Brain tumor research and treatment 2016; (4(1)):1-7 doi:10.14791/btrt.2016.4.1.1.

    PMID: 27195254
  23. 23

    A comparative study of functioning and non-functioning pituitary adenomas.

    Qin J, Li K, Wang X, Bao Y

    Medicine 2021; (100(14)):e25306 doi:10.1097/MD.0000000000025306.

    PMID: 33832102
  24. 24

    A Factorial Analysis on Visual Outcomes of Transsphenoidal Surgery for Pituitary Macroadenoma.

    Ng BCF, Mak CH, Steffi CSY, et al.

    Asian journal of neurosurgery 2022; (17(2)):280-285 doi:10.1055/s-0042-1751011.

    PMID: 36120608
  25. 25

    Agenesis of the dorsal pancreas with chronic suppurative pancreatitis: Case report and literature review.

    Xia LZ, Bu XF, Jiang PC, et al.

    Medicine 2021; (100(49)):e28137 doi:10.1097/MD.0000000000028137.

    PMID: 34889276
  26. 26

    Pancreatic Neuroendocrine Tumor (PNET) Presenting as a Pseudocyst: A Case Report.

    Sedhai S, Mohammed F, Sahtiya S, et al.

    Cureus 2022; (14(9)):e29617 doi:10.7759/cureus.29617.

    PMID: 36320996
  27. 27

    Relationship of each anterior pituitary hormone deficiency to the size of non-functioning pituitary adenoma in the hospitalized patients.

    Mukai K, Kitamura T, Tamada D, et al.

    Endocrine journal 2016; (63(11)):965-976 doi:10.1507/endocrj.EJ16-0168.

    PMID: 27534814
  28. 28

    Collision of Two Tumors: A Case Report of a Lung Adenocarcinoma With Metastasis to a Pituitary Adenoma.

    Borhan MK, Tan FHS, Basry NSA

    Journal of the ASEAN Federation of Endocrine Societies 2022; (37(2)):89-94 doi:10.15605/jafes.037.02.09.

    PMID: 36578883
  29. 29

    Chromogranin A - unspecific neuroendocrine marker. Clinical utility and potential diagnostic pitfalls.

    Gut P, Czarnywojtek A, Fischbach J, et al.

    Archives of medical science : AMS 2016; (12(1)):1-9 doi:10.5114/aoms.2016.57577.

    PMID: 26925113
  30. 30

    Metabolic changes in serum steroids for diagnosing and subtyping Cushing's syndrome.

    Ahn CH, Lee C, Shim J, et al.

    The Journal of steroid biochemistry and molecular biology 2021; (210()):105856 doi:10.1016/j.jsbmb.2021.105856.

    PMID: 33647522
  31. 31

    Plasma tryptophan pathway metabolites quantified by liquid chromatography-tandem mass spectrometry as biomarkers in neuroendocrine tumor patients.

    Johansen SU, Hansen T, Nordborg A, et al.

    Journal of neuroendocrinology 2024; (36(3)):e13372 doi:10.1111/jne.13372.

    PMID: 38361341
  32. 32

    Somatostatin Analogues in the Treatment of Neuroendocrine Tumors: Past, Present and Future.

    Stueven AK, Kayser A, Wetz C, et al.

    International journal of molecular sciences 2019; (20(12)) doi:10.3390/ijms20123049.

    PMID: 31234481

This page provides information on endocrine tumor symptoms and syndromes for educational purposes. Always consult your endocrinologist or oncologist for an accurate diagnosis and testing instructions.

Stay up to date

Get notified when new research about Tumor of endocrine glands is published.

No spam. Unsubscribe anytime.